Boston Scientific drop draws buyer
David Russell | email@example.com
optionMONSTER's Heat Seeker monitoring system detected the purchase of about 2,500 January 12 calls for $0.40. A matching number of January 10 puts was sold at the same time for $0.43, resulting in a credit of $0.03.
Owning calls locks in the price where shares can be purchased in the medical-device company, while selling puts creates an obligation to buy them in the event of a drop. Combining the two strategies lets the investor cheaply position for upside, while also programming a buy order below the current range. Like owning stock, the position has downside risk. (See our Education section for more on the risks and benefits of short puts.)
BSX declined 5.14 percent to $10.70 yesterday as the broader market retreated. It's up 87 percent so far this year, fueled by strong earnings reports. The stock gapped to its highest level in almost four years after its last quarterly release on July 25.
Total option volume in the name was 8 times greater than average in the session, according to the Heat Seeker.